Table 2. Progression to secondary MCL by... | American Society of Hematology

Table 2.

Progression to secondary MCL by preceding diagnosis

Diagnosis before MCL	Number of patients, n/N (%)		Time to MCL progression from initial diagnosis at presentation (y), median (range)
Diagnosis before MCL	Initial diagnosis at presentation	Diagnosis immediately before MCL
ISM	6/27 (22)	1/27 (4)	5.3 (4.4-10.3)
SSM	0/27 (0)	2/27 (7)	Not applicable
ASM	7/27 (26)	11/27 (41)	3.9 (0.8-13.5)
SM-AHN	14/27 (52)	13/27 (48)	0.7 (0.1-7.1)

Diagnosis before MCL	Number of patients, n/N (%)		Time to MCL progression from initial diagnosis at presentation (y), median (range)
Diagnosis before MCL	Initial diagnosis at presentation	Diagnosis immediately before MCL
ISM	6/27 (22)	1/27 (4)	5.3 (4.4-10.3)
SSM	0/27 (0)	2/27 (7)	Not applicable
ASM	7/27 (26)	11/27 (41)	3.9 (0.8-13.5)
SM-AHN	14/27 (52)	13/27 (48)	0.7 (0.1-7.1)